Taking people in GermanyPhase 1
Tests ATX304 safety in healthy adults with overweight or obesity
Tests ATX304, a new medicine, in healthy adults with overweight or obesity.
Key facts
- Who runs it
- Betagenon AB
- Where
- Neuss, GermanySee the site
- Trial code
- Registry title
- A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ATX304
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 64 people, planned
- Started
- 3 Aug 2026
- Expected to end
- 28 Feb 2027
- Type of study
- Interventional
- Record updated
- 30 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 64 years. It tests the safety and effects of ATX304 against a placebo.
- Age
- 18 to 64 years
- Sex
- All sexes can join.
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Germany
- PROFIL Institut fuer Stoffwechselforschung GmbHNeuss, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests ATX304 safety in healthy adults with overweight or obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Fit questions
- Built from 2024-514744-91-00, who can take part
- Record updated
- 30 July 2026